Nanobiotix S.A. NBTX
Set alert
28.28 USD +0.17 +0.60%
As of Nov 3, 9:30 AM ET
28.28 Day range 28.41
18.58 52-week range 57.14
- YTD
- +22.32%
- 1 year
- +35.51%
- Open
- 28.41
- Prev close
- 28.11
- Mkt cap
- 1.44B
- Vol
- 119.20K
- Avg vol
- 148.81K
- EPS
- -1.27
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 28.28
- High
- 28.41
- Forward P/E
- -167.59
- Beta
- 0.53
- Short ratio
- 1.31
- Inst. own
- 11.95%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Apr 27, 2027
- 50-d avg
- 32.53
- 200-d avg
- 33.85
- 1y target
- 54.38
5D chart
Signals (130)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 9:30 AM | 1 day ago |
| MACD: Sell Signal | Nov 2, 9:30 AM | 1 day ago |
| RSI: Oversold | Nov 2, 9:30 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 3:40 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:25 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:35 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:35 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:30 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:05 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:50 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:50 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:45 PM | 3 days ago |
Newest 20 of 130.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 54.38 +92.3% upside
Now 28.28
- Target (low)
- 30.14
- Target (mean)
- 54.38
- Target (high)
- 69.98
Ratings (0m) 5 4 buy · 1 hold · 0 sell
- Strong buy0
- Buy4
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | -0.54088 | -0.70177 – -0.38 | -0.50 | -8.2% | 29.44M | -9.7% | 2 |
| Next year | -0.1493 | -0.21859 – -0.08 | -0.54088 | +72.4% | 44.36M | +50.7% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 4, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| May 1, 2026 | UBS | Maintained | Neutral | Neutral |
| Apr 2, 2026 | Guggenheim | Maintained | Buy | Buy |
| Feb 6, 2026 | Guggenheim | Maintained | Buy | Buy |
| Apr 4, 2025 | Guggenheim | Maintained | Buy | Buy |
| Aug 28, 2024 | Guggenheim | Initiated | — | Buy |
| Dec 8, 2023 | Leerink Partners | Initiated | — | Outperform |
| Jan 6, 2021 | Evercore ISI Group | Initiated | — | Outperform |